menu
    • menu

    Company profile for RadioMedix

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    RadioMedix, Inc. is a clinical-stage biotechnology company, based in Texas, focused on innovative targeted radiopharmaceuticals for diagnosis, monitoring, and therapy of cancer. We commercialize radiopharmaceuticals for PET imaging and targeted alpha and beta-emitter therapy. Our operations cover the entire value chain from drug discovery to sponsoring and conducting clinical trials to scale up manufacturing. RadioMedix is c...
    RadioMedix, Inc. is a clinical-stage biotechnology company, based in Texas, focused on innovative targeted radiopharmaceuticals for diagnosis, monitoring, and therapy of cancer. We commercialize radiopharmaceuticals for PET imaging and targeted alpha and beta-emitter therapy. Our operations cover the entire value chain from drug discovery to sponsoring and conducting clinical trials to scale up manufacturing. RadioMedix is compliant with 21 CFR Parts 210,211,212. Our Molecular Core Facility supports the synthesis, and the pre-clinical evaluation of our drugs and contract projects.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    RadioMedixUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    9701 Richmond Avenue, Suite 222 Houston, Texas 77042
    Telephone
    Telephone
    713-358-6500
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://radiomedix.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/radiomedix-inc-/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    RadioMedix Expands Thorium-228 Supply Network
    RadioMedix Expands Thorium-228 Supply Network

    12 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/12/3204602/0/en/RadioMedix-Expands-Thorium-228-Supply-Network-Through-New-Agreement-With-Van-Overeem-Nuclear-B-V.html

    GLOBENEWSWIRE
    12 Dec 2025
    Share Share
    Radio Medix & Thor Medical Enter Supply Agreement for Thorium-228
    Radio Medix & Thor Medical Enter Supply Agreement for Thorium-228

    04 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/04/3199634/0/en/RadioMedix-and-Thor-Medical-enter-supply-agreement-for-thorium-228.html

    GLOBENEWSWIRE
    04 Dec 2025
    Share Share
    First Patient Dosed in 203Pb-RMX-VH-PIB Study for Cancer
    First Patient Dosed in 203Pb-RMX-VH-PIB Study for Cancer

    11 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/11/3148395/0/en/RadioMedix-and-Vect-Horus-Announce-First-Patient-Dosed-in-Exploratory-Clinical-Study-of-203Pb-RMX-VH-PIB-for-Glioblastoma-Multiforme-and-Pancreatic-Ductal-Adenocarcinoma.html

    GLOBENEWSWIRE
    11 Sep 2025
    Share Share
    RadioMedix Introduces ²¹²Pb Generator for Alpha Therapy
    RadioMedix Introduces ²¹²Pb Generator for Alpha Therapy

    12 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/12/3098408/0/en/RadioMedix-Debuts-Proprietary-bench-top-Pb-Generator-to-Support-Targeted-Alpha-Therapy-Development.html

    GLOBENEWSWIRE
    12 Jun 2025
    Share Share
    Sanofi, RadioMedix, Orano Med Partner On Radioligand For Rare Cancers
    Sanofi, RadioMedix, Orano Med Partner On Radioligand For Rare Cancers

    12 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/12/2944919/0/en/Press-Release-Sanofi-RadioMedix-and-Orano-Med-announce-licensing-agreement-on-next-generation-radioligand-medicine-for-rare-cancers.html

    GLOBENEWSWIRE
    12 Sep 2024
    Share Share
    RadioMedix & Orano receive FDA Breakthrough Therapy Designation for AlphaMedixTM
    RadioMedix & Orano receive FDA Breakthrough Therapy Designation for AlphaMedixTM

    12 Feb 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240212199538/en

    BUSINESSWIRE
    12 Feb 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search